Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study

Early type 2 diabetes mellitus (DM) may only require lifestyle modifications for glycemic control without the need for oral hypoglycemic agents (OHAs). Metformin is believed to improve cardiovascular outcomes in patients with DM, and it is considered to be a first-line therapy. However, it is unclea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Lee, Kuang-Tso, Yeh, Yung-Hsin, Chang, Shang-Hung, See, Lai-Chu, Lee, Cheng-Hung, Wu, Lung-Sheng, Liu, Jia-Rou, Kuo, Chi-Tai, Wen, Ming-Shien
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2017
Assuntos:
3400
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5515773/
https://ncbi.nlm.nih.gov/pubmed/28700501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000007507
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados